On Monday, the Cambridge-based company Moderna announced that the first phase of testing of its COVID-19 vaccine has delivered positive results. Dr. Sandro Galea, dean of the Boston University School of Public Health, joins us to give an update on what we know, and what we still don't, about treating COVID-19 patients.